0775:HKG
CK Life Sciences Intl (Holdings) Inc
0,51 HK$
0,00%
(0,00) 1D
16 հոկ, 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0775...
Open
0,51 HK$
High
0,52 HK$
Low
0,51 HK$
Mkt. cap
4,90 մլրդ
Avg. vol.
1,66 մլն
Volume
956,00 հզր
52-wk high
1,02 HK$
52-wk low
0,51 HK$
EPS
-0,01 HK$
Shares outstanding
9,61 մլրդ
No. of employees
2 հզր
Open
0,51 HK$
High
0,52 HK$
Low
0,51 HK$
Mkt. cap
4,90 մլրդ
Avg. vol.
1,66 մլն
Volume
956,00 հզր
52-wk high
1,02 HK$
52-wk low
0,51 HK$
EPS
-0,01 HK$
Shares outstanding
9,61 մլրդ
No. of employees
2 հզր
News stories
From web sources and news partners
Bloomberg.com
·
1 ժամ առաջ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Yahoo Finance
·
14 ժամ առաջ
Michael Burry Warns of a Stock Market ‘Supervolcano’
MarketWatch
·
9 ժամ առաջ
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Seeking Alpha
·
3 ժամ առաջ
SH: A Tactical Hedge, But Not Yet A Short Call (NYSEARCA:SH)
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc